Why the study?
Do antipsychotic drugs increase the risk of prolonged QTc interval, torsade de pointes, and sudden death?
Do antipsychotic drugs increase the risk of prolonged QTc interval, torsade de pointes, and sudden death?
Certain antipsychotic drugs, particularly thioridazine, carry a significant risk of QTc prolongation, torsade de pointes, and sudden death, requiring careful risk-benefit consideration in psychiatric treatment.
May inform antipsychotic selection to reduce sudden death risk; leaves open randomized confirmation of observed associations.
Although pimozide, sertindole, droperidol, and haloperidol have been documented to cause torsade de pointes and sudden death, the most marked risk is with thioridazine. There is no association with olanzapine, quetiapine, or risperidone. Ziprasidone does prolong the QT interval, but there is no evidence to suggest that this leads to torsade de pointes or sudden death. Only widespread use will prove if ziprasidone is entirely safe. To date, all antipsychotic drugs have the potential for serious adverse events. Balancing these risks with the positive effects of treatment poses a challenge for psychiatry.
No takes yet. Share an insight, caveat, or question.
Glassman et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: